Parkside Financial Bank & Trust Dyne Therapeutics, Inc. Put Options Transaction History
Parkside Financial Bank & Trust
- $772 Million
- Q1 2025
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding DYN
# of Institutions
202Shares Held
105MCall Options Held
84.8KPut Options Held
409K-
Atlas Venture Life Science Advisors, LLC9.13MShares$108 Million27.97% of portfolio
-
Vanguard Group Inc Valley Forge, PA7.41MShares$87.6 Million0.0% of portfolio
-
Black Rock Inc. New York, NY7.39MShares$87.4 Million0.01% of portfolio
-
Janus Henderson Group PLC London, X07.38MShares$87.3 Million0.09% of portfolio
-
Ra Capital Management, L.P. Boston, MA6.38MShares$75.5 Million2.43% of portfolio
About Dyne Therapeutics, Inc.
- Ticker DYN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 51,765,400
- Market Cap $612M
- Description
- Dyne Therapeutics, Inc., a muscle disease company, operates as a biotechnology company that focuses on advancing therapeutics for genetically driven muscle diseases in the United States. It develops various programs for myotonic dystrophy type 1, duchenne muscular dystrophy, and facioscapulohumeral dystrophy, as well as rare skeletal muscle, and...